REQUEST A DEMO
Total
USD $0.00
Search more companies

Golden Biotechnology Corp. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Golden Biotechnology Corp. Profile Updated: June 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Golden Biotechnology Corporation (GBC), founded by Mr. Liu Sheng Yung in 2002, is an innovative drug discovery and herbal supplement company dedicated to enhance lives by developing highly quality products that prevent and treat diseases.Antroquinonol had been applied for compound and use patents worldwide. Antroquinonol has been approved by USFDA in January and TFDA in April of 2010 for IND. GDAC currently have been exported to China, Singapore, Malaysia and Japan. Golden Biotech started the phase I clinical trial on NSCLC patients and signed the contract agreement with PharmaNet as its CRO to monitor the clinical trial at medical centers in the US and Taiwan.

Headquarters
15Th Fl., No.27-6, Sec.2, Chung Cheng East Rd., Tamsui Town
Taipei City; Taipei City;

Contact Details: Purchase the Golden Biotechnology Corp. report to view the information.

Website: http://www.goldenbiotech.com.tw

Basic Information
Total Employees:
Purchase the Golden Biotechnology Corp. report to view the information.
Outstanding Shares:
Purchase the Golden Biotechnology Corp. report to view the information.
Financial Auditors:
Purchase the Golden Biotechnology Corp. report to view the information.
Incorporation Date:
September 27, 2002
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
2.85%
Purchase this report to view the information.
1.55%
Purchase this report to view the information.
1.1%
Purchase this report to view the information.
0.73%
Purchase this report to view the information.
0.65%
Subsidiaries
Golden Biotechnology Corp. (De) (United States)
100%
Goldenbiotech Nology Japan (Japan)
100%
Pt Royal Golden Biotechnology (Indonesia)
99.98%
Company Performance
Financial values in the chart are available after Golden Biotechnology Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-20.55%
Total operating revenue
-20.55%
Operating profit (EBIT)
-7.08%
EBITDA
-21.21%
Net Profit (Loss) for the Period
-12.35%
Total assets
-38.19%
Total equity
-61.21%
Operating Profit Margin (ROS)
-181.03%
Net Profit Margin
-205.14%
Return on Equity (ROE)
-43.74%
Debt to Equity Ratio
86.43%
Quick Ratio
-1.16%
Cash Ratio
-0.93%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?